Delhi AbbVie, a global biopharmaceutical leader committed to developing innovative medicines and solutions, hosted the National Conclave on World Retina Day at the India Habitat Centre, Delhi, to spotlight Diabetic Macular Edema (DME), one of the leading causes of vision loss among people living with diabetes. According to 2025 report by the Cleveland Clinic, about 1 in every 14 people with diabetes develops DME. The event brought together renowned experts to foster greater awareness about vision loss due to diabetes, which is called diabetes macular edema (DME) and explore collaborative approaches to address the growing retinal disease burden in India.

The conclave reinforced that while evidence-based treatments have significantly improved patient outcomes, critical challenges persist. L

See Full Page